HER2 Is Not a Cancer Subtype but Rather a Pan-Cancer Event HER2 Is Not a Cancer Subtype but Rather a Pan-Cancer Event

Research in breast cancer genomics reveals the potential for combining anti-HER2 therapy with anti-androgen agents.Breast Cancer Research

Source: Medscape Today Headlines - March 22, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news